← Back to Search

TENS for Chronic Pain

N/A
Recruiting
Led By Guillaume Léonard, PhD
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Being off work completely due to a musculoskeletal injury
Being 55 years of age or older
Must not have
Having already experimented with TENS
Being diagnosed with cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months

Summary

This trial is testing whether a remote rehabilitation intervention combining therapeutic exercises and electrical nerve stimulation (TENS) can help people aged 55 and over who have stopped working due to pain. Different feasibility indicators and clinical measures will be used to evaluate the effect of the intervention.

Who is the study for?
This trial is for individuals aged 55 or older who are off work due to musculoskeletal injuries, starting physical rehab, and can handle basic tech like video calls and texts. They should speak French, have stable medication routines, mild to moderate pain during movement, and not have used TENS before.
What is being tested?
The study tests if combining therapeutic exercises with real or placebo TENS via telerehabilitation helps in work rehabilitation for older adults. It's a triple-blind study where neither participants nor researchers know who gets the real treatment until after the results.
What are the potential side effects?
TENS is generally safe but may cause skin irritation at the electrode sites or muscle twitching. Some people might feel uncomfortable sensations from the electrical current.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently not working due to a musculoskeletal injury.
Select...
I am 55 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have tried using a TENS unit for pain relief.
Select...
I have been diagnosed with cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence rate
Attrition rate
Exclusion rate
+3 more
Secondary study objectives
Disability in work Rehabilitation
Overall treatment satisfaction
Pain catastrophizing
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention groupExperimental Treatment1 Intervention
Real TENS and personalized exercise program in telerehabilitation (3 sessions/week over 3 weeks) n = 12
Group II: Control groupPlacebo Group1 Intervention
Simulated TENS and personalized exercise program in telerehabilitation (3 sessions/week over 3 weeks) n = 12
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TENS
2011
Completed Phase 2
~2040

Find a Location

Who is running the clinical trial?

Réseau québécois de recherche sur le vieillissement (RQRV)UNKNOWN
1 Previous Clinical Trials
32 Total Patients Enrolled
Université de SherbrookeLead Sponsor
304 Previous Clinical Trials
76,705 Total Patients Enrolled
11 Trials studying Chronic Pain
1,124 Patients Enrolled for Chronic Pain
Réseau Provincial De Recherche En Adaptation-Réadaptation (REPAR)UNKNOWN
1 Previous Clinical Trials
37 Total Patients Enrolled

Media Library

TENS Clinical Trial Eligibility Overview. Trial Name: NCT05316623 — N/A
Chronic Pain Research Study Groups: Control group, Intervention group
Chronic Pain Clinical Trial 2023: TENS Highlights & Side Effects. Trial Name: NCT05316623 — N/A
TENS 2023 Treatment Timeline for Medical Study. Trial Name: NCT05316623 — N/A
~11 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top